Residency · Residency · Medical Genetics Genomics
Hereditary Aortopathies: Marfan Syndrome and Related Disorders
Introduction
Hereditary thoracic aortic disease (HTAD) encompasses a group of genetic conditions predisposing to aortic aneurysm and dissection, often with systemic connective tissue manifestations. Marfan syndrome is the prototype, but numerous additional genes and syndromes are now recognized. Collectively, HTAD accounts for approximately 20% of thoracic aortic aneurysms and dissections (TAAD), and early identification enables life-saving surgical intervention and surveillance.
Marfan Syndrome
Genetics
Marfan syndrome is caused by pathogenic variants in FBN1 (fibrillin-1) on chromosome 15q21 and follows autosomal dominant inheritance, with approximately 25% representing de novo mutations. Over 3,000 variants have been reported, and most are private (family-specific). Both haploinsufficiency and dominant-negative mechanisms have been described.
Revised Ghent Nosology (2010 Diagnostic Criteria)
The diagnosis of Marfan syndrome can be established through several combinations. Aortic root dilatation (Z-score of 2 or greater) or dissection plus ectopia lentis meets criteria regardless of FBN1 status. Aortic root dilatation plus a pathogenic FBN1 variant is sufficient. Aortic root dilatation plus a systemic score of 7 or greater also establishes the diagnosis. The systemic score incorporates wrist and thumb signs, pectus deformity, hindfoot valgus, pneumothorax, dural ectasia, protrusio acetabuli, scoliosis, and skin striae.
Clinical Features
Cardiovascular features include aortic root aneurysm at the sinuses of Valsalva, aortic dissection, mitral valve prolapse, and mitral regurgitation. Ocular findings include ectopia lentis (upward subluxation in approximately 60%), myopia, and risk of retinal detachment. Skeletal manifestations include tall stature, arachnodactyly, pectus excavatum or carinatum, scoliosis, and joint hypermobility. Pulmonary features include spontaneous pneumothorax and apical blebs. Dural ectasia is assessed by lumbosacral MRI.
Loeys-Dietz Syndrome (LDS)
Genetics
Loeys-Dietz syndrome results from pathogenic variants in TGF-beta signaling pathway genes. LDS types 1 and 2 involve TGFBR1 and TGFBR2 (the most common), LDS type 3 involves SMAD3, LDS type 4 involves TGFB2, and LDS type 5 involves TGFB3. Inheritance is autosomal dominant with approximately 25% de novo.
Key Features
LDS is characterized by aggressive arterial disease, with aneurysms and dissections occurring at smaller diameters and younger ages than in Marfan syndrome. Arterial tortuosity is present throughout the arterial tree. Craniofacial features in types 1 and 2 include hypertelorism, bifid uvula or cleft palate, and craniosynostosis. Additional features include cervical spine instability, club foot, and thin or translucent skin. The dissection threshold is often lower than in Marfan syndrome, necessitating earlier surgical intervention.
Vascular Ehlers-Danlos Syndrome (vEDS)
Genetics
Vascular EDS is caused by pathogenic variants in COL3A1 (type III collagen), follows autosomal dominant inheritance, and is de novo in approximately 50% of cases. Glycine substitutions in the triple-helical domain are generally more severe than haploinsufficiency variants.
Clinical Features
Arterial rupture occurs not only in the aorta but in medium-sized arteries including mesenteric, iliac, and splenic. Bowel perforation, particularly of the sigmoid colon, is characteristic. Uterine rupture during pregnancy is a life-threatening complication. Physical features include thin, translucent skin with visible veins, easy bruising, and characteristic facial features (thin lips, small chin, prominent eyes). Median survival is approximately 50 years without management.
Management Considerations
Surgery is extremely high-risk due to tissue fragility, and endovascular approaches are preferred when possible. Celiprolol has been shown to reduce vascular events in a randomized trial. Invasive procedures, contact sports, and Valsalva maneuvers should be avoided.
| Condition | Gene(s) | Key Vascular Feature | Surgery Threshold (Aortic Root) | Distinguishing Features |
|---|---|---|---|---|
| Marfan syndrome | FBN1 | Aortic root aneurysm (sinuses of Valsalva) | 5.0 cm (or 4.5 cm with risk factors) | Ectopia lentis; tall stature; systemic score |
| Loeys-Dietz syndrome | TGFBR1/2, SMAD3, TGFB2/3 | Aggressive aneurysm/dissection at smaller sizes | 4.0–4.5 cm (gene/phenotype-dependent) | Arterial tortuosity; hypertelorism; bifid uvula |
| Vascular EDS | COL3A1 | Medium-artery rupture; bowel perforation | Surgery avoided if possible (tissue fragility) | Thin translucent skin; NO lens/skeletal findings |
| FTAAD (nonsyndromic) | ACTA2, MYH11, SMAD3, others | Aortic aneurysm/dissection without syndromic features | 4.5–5.0 cm (gene-dependent) | May have livedo reticularis (ACTA2); PDA (MYH11) |
| Turner syndrome (45,X) | — | Bicuspid aortic valve; coarctation; aortic dissection | ASI-indexed thresholds | Short stature; ovarian insufficiency |
Other Hereditary Aortopathies
Familial Thoracic Aortic Aneurysm and Dissection (FTAAD)
Non-syndromic autosomal dominant TAAD involves key genes including ACTA2 (accounting for approximately 15% of familial TAAD), MYH11, PRKG1, MYLK, LOX, and MFAP5. ACTA2 is notable for its association with TAAD plus livedo reticularis, iris flocculi, premature stroke, moyamoya, and coronary artery disease.
Other Conditions
Turner syndrome (45,X) predisposes to aortic coarctation, dissection, and bicuspid aortic valve. Bicuspid aortic valve carries associated aortopathy in approximately 20% of cases, with a partially understood genetic basis involving NOTCH1. Arterial tortuosity syndrome results from SLC2A10 variants and follows autosomal recessive inheritance with diffuse arterial tortuosity and aneurysms.
Genetic Testing
Indications
Genetic testing is indicated for clinical features of a known aortopathy syndrome, thoracic aortic aneurysm or dissection before age 60, family history of TAAD or unexplained sudden death, and aortic root dilatation with Z-score of 2 or greater.
Testing Approach
Aortopathy gene panels (15-30+ genes) are the most common approach and should include FBN1, TGFBR1/2, SMAD3, TGFB2/3, COL3A1, ACTA2, MYH11, LOX, PRKG1, MYLK, and FBN2. Exome or genome sequencing is considered if the panel is negative and clinical suspicion is high. A molecular diagnosis is identified in approximately 25-30% of familial TAAD cases and up to 75-90% of clinically diagnosed Marfan syndrome or LDS.
Cascade Testing
All first-degree relatives should be tested once a pathogenic variant is identified. Gene-positive, phenotype-negative individuals require ongoing imaging surveillance.
Aortic Surveillance and Surgical Thresholds
Imaging
Echocardiography is the primary tool for aortic root monitoring, with measurement at the sinuses of Valsalva. CT angiography or MRA provides complete aortic assessment including ascending aorta, arch, and descending segments. Imaging frequency is every 6-12 months initially, transitioning to annual monitoring once stability is confirmed.
Surgical Thresholds (Aortic Root)
For Marfan syndrome, surgery is indicated at 5.0 cm or greater (or 4.5 cm with risk factors such as family history of dissection, rapid growth exceeding 0.5 cm per year, or significant aortic regurgitation). For Loeys-Dietz syndrome, the threshold is lower at 4.0-4.2 cm due to aggressive disease. For vascular EDS, surgery is avoided unless a life-threatening emergency exists. For ACTA2, the threshold is 4.5 cm. Valve-sparing aortic root replacement is preferred when technically feasible.
Medical Management
Beta-blockers are the standard of care to reduce aortic wall stress and rate of dilatation. Losartan and other ARBs offer theoretical benefit through TGF-beta pathway modulation, with mixed clinical trial results but use as an adjunct. Restriction of isometric exercise, contact sports, and competitive athletics is recommended. Pregnancy carries high risk in Marfan syndrome and LDS, requiring preconception counseling, beta-blocker continuation, serial imaging, and planned delivery.
Clinical Pearls
Loeys-Dietz syndrome has lower surgical thresholds than Marfan syndrome because dissection can occur at aortic diameters considered safe in Marfan. Vascular EDS (COL3A1) involves medium-sized arteries, not just the aorta, placing the entire arterial tree at risk, and surgical repair is complicated by tissue fragility. ACTA2 is the most common gene for non-syndromic familial TAAD and is associated with extra-aortic vascular disease including stroke, coronary artery disease, and moyamoya. A negative genetic test does not exclude hereditary aortopathy -- approximately 70% of familial TAAD cases remain genotype-negative, and clinical surveillance should continue based on family history.
References
- Loeys BL, Dietz HC, Braverman AC, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet. 2010;47(7):476-485.
- Isselbacher EM, Preventza O, Hamilton Black J III, et al. 2022 ACC/AHA guideline for the diagnosis and management of aortic disease. J Am Coll Cardiol. 2022;80(24):e223-e393.
- MacCarrick G, Black JH III, Bowdin S, et al. Loeys-Dietz syndrome: a primer for diagnosis and management. Genet Med. 2014;16(8):576-587.
- Byers PH, Belmont J, DeStefano J, et al. Diagnosis, natural history, and management in vascular Ehlers-Danlos syndrome. Am J Med Genet C. 2017;175(1):40-47.